Gemcitabine/cisplatin in advanced transitional cell carcinoma of the urinary tract (TCC): A phase II multicenter trial

被引：5
|
作者：
Mancarella, S [1 ]
Lorusso, V [1 ]
Manzione, L [1 ]
Antimi, M [1 ]
De Vita, F [1 ]
Santoro, A [1 ]
Maiorino, L [1 ]
Mattioli, R [1 ]
Luporini, G [1 ]
Bilancia, D [1 ]
De Lena, M [1 ]
机构：
[1] Univ Bari, Italian Cooperat Study Bladder Canc Oncol Inst, I-70121 Bari, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81821-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1405
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [1] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
    Lorusso, V
    Manzione, L
    De Vita, F
    Antimi, M
    Selvaggi, FP
    De Lena, M
    [J]. JOURNAL OF UROLOGY, 2000, 164 (01): : 53 - 56
  • [2] A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC).
    Olivares, J
    Hyman, W
    Senzer, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 404S - 404S
  • [3] Phase II trial of Gemcitabine-Carboplation combination in advanced transitional cell cancer (TCC) of bladder and urinary tract
    Sundar, Santhanam
    Sokal, Mike
    Lees, Kathryn
    Osborne, Lynne
    Carmichael, James
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 118 - 118
  • [4] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 409S - 409S
  • [5] Phase II trial of gemcitabine, paclitaxel, and cisplatin in advanced transitional cell carcinoma.
    Clark, PE
    Stindt, D
    Hall, MC
    Harmon, M
    Lovato, JF
    Mohler, R
    Kimbrough, C
    Torti, FM
    [J]. JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
  • [6] Phase I trial of paclitaxel, cisplatin, and gemcitabine (TCG) in patients (p) with advanced transitional cell carcinoma (TCC) of the urothelium
    Bellmunt, J
    Baselga, J
    [J]. SEMINARS IN ONCOLOGY, 1999, 26 (01) : 140 - 140
  • [7] Gemcitabine (GEM) and cisplatin (CIS) is an active regimen for advanced transitional cell carcinoma (TCC): Results of a phase II study
    Moore, M
    Tannock, I
    Winquist, E
    Tolcher, A
    Bennett, K
    Seymour, L
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 169 - 169
  • [8] Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:: Phase II study.
    Adamo, V
    D'Angelo, A
    Ferraro, G
    Alafaci, E
    Altavilla, G
    Garipoli, C
    Magno, C
    Scimone, A
    Zanghì, M
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 79 - 79
  • [9] Sequential administration of cisplatin (C), gemcitabine (G) and docetaxel (D), as first-line treatment in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract: A multicenter phase II study
    Androulakis, N.
    Boukovinas, I.
    Bozionelou, V.
    Kalykaki, A.
    Potamianou, A.
    Pallis, A.
    Vamvakas, L.
    Gkioulbasanis, I.
    Souglakos, I.
    Sfakiotaki, G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 151 - 151
  • [10] Phase II trial of cisplatin (C), fixed-dose rate gemcitabine (G) and gefitinib for advanced transitional cell carcinoma (TCC) of the urothelial tract: Preliminary results of CALGB 90102.
    Philips, G
    Halabi, S
    Sanford, B
    Bajorin, D
    Small, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 391S - 391S
12345